(8)Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val- (8) Preparation of Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-resin: (7)Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-1050530105010603DMF3DMF2DMFFmoc-Pro-OHDIEATBTU/HOBtHBTU/HOBtBOP/HOBt105010603DMF3DMF2Fmoc-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val- In the Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-resin of step (7), add decapping reagent 1050 and react for 530 minutes, dry with vacuum pump, re- Add capping reagent and react at 10-50C for 10-60 minutes, pump dry, wash with isopropanol for 3 times, DMF for 3 times, distilled DMF for 2 times, add Fmoc-Pro-OH and DIEA dissolved in DMF , a mixture of TBTU/HOBt or HBTU/HOBt or BOP/HOBt, react at 10-50C for 10-60 minutes, dry it with a vacuum pump, wash 3 times with isopropanol, wash 3 times with DMF, wash 2 times with re-distilled DMF time, drained to obtain Fmoc-Pro-Ala-Asp (otBu)-Asp (otBu)-Ala-Gly-Leu-Val-resin
28 Globally, the reported prevalence of AMS, HACE, and HAPE varies significantly due to differences in these confounding variables, as well as study designs and biases
As we previously stated in the CY 2024 PFS final rule the incentive is for all payer/all patient eCQM/MIPS CQM reporting
doi: 10.1186/s10194-020-1078-9 48 YangJZhengPLiYWuJTanXZhouJet al
